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H ypertension, an important component of metabolic syndrome and one of the most important contributors to cardiovascular disease, 1-5 strongly correlates with measures of lipid metabolism. [6] [7] [8] [9] [10] Traditionally, total serum cholesterol, triglyceride, high-density lipoprotein (HDL), and low-density lipoprotein (LDL) concentrations in plasma are considered important and clinically useful biomarkers of hypertension. The next level of resolution is offered by the lipoprotein fractions such that differential relative abundance of some HDL or LDL fractions can provide a more informative picture of hypertension pathophysiology. [11] [12] [13] Dyslipidemia is a characteristic feature of hypertension. Subsequent and consequent visceral fat deposition 14 and endothelial dysfunction are hallmarks of early essential hypertension. 15, 16 In this context, a deeper understanding of the perturbed lipid homeostasis in the pathophysiology of hypertension is needed.
More recently, Graessler et al 17 demonstrated that the rapidly evolving technology of plasma lipidomic profiling can be used effectively to characterize the lipid metabolism changes associated with hypertension and other components of metabolic syndrome. For example, hypertension was independently associated with the ether phosphatidylcholine, ether phosphatidylethanolamine, and triacylglycerol classes more strongly compared with the routinely used clinical measures of lipid metabolism derangement. 17 The combination of liquid chromatography with mass spectroscopy has proved to be extremely valuable in the identification and quantification of a plethora of lipid species and their associations with complex
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Abstract-Both as a component of metabolic syndrome and as an independent entity, hypertension poses a continued challenge with regard to its diagnosis, pathogenesis, and treatment. Previous studies have documented connections between hypertension and indicators of lipid metabolism. Novel technologies, such as plasma lipidomic profiling, promise a better understanding of disorders in which there is a derangement of the lipid metabolism. However, association of plasma lipidomic profiles with hypertension in a high-risk population, such as Mexican Americans, has not been evaluated before. Using the rich data and sample resource from the ongoing San Antonio Family Heart Study, we conducted plasma lipidomic profiling by combining high-performance liquid chromatography with tandem mass spectroscopy to characterize 319 lipid species in 1192 individuals from 42 large and extended Mexican American families. Robust statistical analyses using polygenic regression models, liability threshold models, and bivariate trait analyses implemented in the SOLAR software were conducted after accounting for obesity, insulin resistance, and relative abundance of various lipoprotein fractions. Diacylglycerols, in general, and the DG 16:0/22:5 and DG 16:0/22:6 lipid species, in particular, were significantly associated with systolic blood pressure (SBP), diastolic blood pressure (DBP), and mean arterial pressure (MAP), as well as liability of incident hypertension measured during 7140.17 person-years of follow-up. Four lipid species, including the DG 16:0/22:5 and DG 16:0/22:6 species, showed significant genetic correlations with the liability of hypertension in bivariate trait analyses. Our results demonstrate the value of plasma lipidomic profiling in the context of hypertension and identify disturbance of diacylglycerol metabolism as an independent biomarker of hypertension.
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diseases. [18] [19] [20] [21] [22] The advantages of this method are high resolution, accuracy, and associative information at the level of lipid species. 23, 24 It is noteworthy that serum lipidomic studies have already offered critical insights in the pathogenesis of complex diseases, such as obesity and insulin resistance. 22, 25, 26 Initial studies in relation to hypertension have also been very encouraging, although generally limited by small sample sizes and lower resolution of lipidomic profiling. 17, 27 Mexican Americans account for 66% of the US Hispanic population and are at a high risk of dyslipidemia and insulin resistance. 28 Despite this, to our knowledge, currently there are no studies available that characterize the serum lipidomic profile and associate it with the risk of hypertension in this population. The San Antonio Family Heart Study (SAFHS) is an ongoing study of large extended Mexican American families. 29, 30 Using the rich data and sample resource from this study, we conducted an investigation into the association of plasma lipid profile with blood pressure and hypertension. We hypothesized that specific lipid species associate with the risk of hypertension in the study subjects independently of lipoprotein fractions. Here, we present the results that demonstrate a strong and independent association of some lipid species with hypertension-related traits.
Methods
Study Participants
The SAFHS focuses on 1431 individuals of 42 Mexican American families in San Antonio. Details of this collaborative study have been described elsewhere. 29, 30 Briefly, the aim of SAFHS is to quantify the relative contributions of genetic and environmental factors to the risk of developing cardiovascular diseases and metabolic syndrome. Extensive phenotypic assessment for several traits related to metabolic syndrome has been performed in these individuals. This project involving the Texas Biomedical Research Institute and the University of Texas Health Science Center at San Antonio was initiated in 1991. Informed consent was obtained from all participants before collection of samples. The Institutional Review Board of the University of Texas Health Sciences Center at San Antonio approved the study. For this study, we included data on participants who were followed up for ≤2 additional visits spaced ≈5 years apart in addition to the enrollment visit. The details of data collection are described elsewhere. 29, 30 We included a total of 1192 subjects, for whom blood pressure data at the time of enrollment were available. The mean age of the study subjects at the first clinic visit was 39.42 years (SD 16.89), and 63% were women.
Outcomes and Predictors
We studied the association of a total of 319 plasma lipid species with the following 4 hypertension-related traits: SBP, DBP, MAP, and liability of incident hypertension. Of these, SBP and DBP were cross-sectionally measured on the same day on which the blood sample for lipidomic profiling was drawn, and MAP was defined as DBP+([SBP−DBP]/3). Measurement procedures for SBP and DBP have been described previously. 31, 32 Briefly, these measurements were conducted using a random-zero sphygmomanometer on the left arm. To account for the potential variability in the blood pressure measurements, we measured the blood pressure thrice with 5-minute intervals but used the average of the last 2 readings as the phenotypic trait value. In this study, the mean (SD) SBP, DBP, and MAP were 120.44 (18.73), 70.65 (10.33), and 87.25 (11.59) mm Hg, respectively. Incident hypertension was defined as SBP >140 mm Hg or DBP >90 mm Hg or history of antihypertensive treatment during the follow-up visits in subjects who were normotensive at enrollment. For the outcome of incident hypertension, we, therefore, excluded subjects on whom data for all 3 visits were not available or who were detected to have hypertension at enrollment or who were already receiving antihypertensive treatment. These data were available on 736 subjects and represented a total follow-up of 7140.17 person-years. Of these 736 subjects, 250 (34.0%) developed hypertension during follow-up, with an incidence rate of 35.0 new cases of hypertension per 1000 study subjects per year.
To examine the independence of the association of lipid species with the abovementioned outcomes, we adjusted for the following variables in regression models: age, age 2 , sex, age×sex interaction, age 2 ×sex interaction, 8 HDL fractions (HDL1, HDL2b1, HDL2b2, HDL2a, HDL3a, HDL3b, HDL3c1, and HDL3c2), 5 LDL fractions (LDL1, LDL2, LDL3, LDL4a, and LDL4b), body mass index (as a measure of obesity), homeostasis model of assessment-insulin resistance (as a measure of insulin resistance), and use of lipid-lowering drugs. For the outcomes of SBP, DBP, and MAP, we additionally included use of antihypertensive drugs as a covariate. Methods of assessment of the relative abundance of lipoprotein fractions in SAFHS have been described elsewhere. 33 Body mass index was estimated as weight (kg)/height 2 (m), whereas homeostasis model of assessment-insulin resistance was estimated as fasting glucose (mmol/L)×fasting insulin (μU/mL)/22.5. 34
Lipidomic Studies
Samples were analyzed in the Metabolomics Laboratory, Baker IDI Heart and Diabetes Institute. A 10-μL aliquot of plasma was combined with 200 μL CHCl 3 /MeOH (2:1) and 15 μL of internal standard mix and then briefly vortexed. Samples were mixed (rotary mixer, 10 minutes), sonicated (water bath, 30 minutes), and then allowed to stand (20 minutes) at room temperature. Samples were centrifuged (16 000g, 10 minutes), and the supernatant was dried under a stream of nitrogen at 40°C. The extracted lipids were resuspended in 50 μL H 2 O-saturated BuOH with sonication (10 minutes), followed by 50 μL of 10 mmol/L NH 4 CHOO in MeOH. Extracts were centrifuged (3350g, 5 minutes), and the supernatant was transferred into 0.2-mL glass inserts in vials with Teflon-lined caps. Mass spectrometric analysis was performed using 5 and 1 μL (for triacylglycerol and diacylglycerol species) injections of the lipid extracts.
Identification and quantification of lipid species were performed by liquid chromatography-electrospray ionization tandem mass spectrometry using an Applied Biosystems 4000 QTRAP. Liquid chromatography was performed on a Zorbax C18, 1.8 µm, 50×2.1 mm column at 300 µL/min using the following gradient conditions: 0% B to 100% B over 8.0 minutes, 2.5 minutes at 100% B, a return to 0% B over 0.5 minutes, and then 3.0 minutes at 0% B before the next injection. Diacylglycerols and triacylglycerols were separated using the same solvent system with an isocratic flow (100 μL/min) of 85% B over 6 minutes. Solvents A and B consisted of tetrahydrofuran:methanol:water in the ratios of 30:20:50 and 75:20:5, respectively, both containing 10 mmol/L NH 4 CHOO. Quantification of individual lipid species was then performed using scheduled multiple reaction monitoring in positive ion mode. 35, 36 Lipid concentrations were calculated by relating the peak area of each species to the peak area of the corresponding internal standard. Cholesterol ester species were corrected for response factors determined for each species. Total measured lipids of each class were calculated by summing the individual lipid species.
Statistical Analysis
We examined the association of each lipid species with hypertensionrelated traits. For this, we ran polygenic models with the given lipid species as an independent variable, along with the covariates mentioned earlier. For the outcome of incident hypertension, we used a liability threshold model in which an individual was considered to belong to the hypertensive class if the latent, multivariate normal liability of that individual (based on the kinship structure) exceeded a threshold of 0. Relative risk of incident hypertension was determined Benjamini and Hochberg. In addition, we also estimated the phenotypic variability in SBP, DBP, and MAP explained by each lipid species using variance components approach. 37 For the dichotomous trait of incident hypertension, we estimated the Kullback-Leibler R 2 based on the information distance 38 as a measure of the explained variance.
Next, we conducted bivariate trait analyses in which we used each lipid species in a separate bivariate trait polygenic model along with liability of incident hypertension as the 2 traits. We, thus, estimated the genetic correlation (ρ g ) and the environmental correlation (ρ e ) coefficients. The statistical significance of these correlation coefficients was tested by constraining the respective parameters to zero and estimating the χ 2 statistics as mentioned above. All genetic analyses were conducted using the SOLAR software. 37 Statistical significance was assessed at a global type I error rate of 0.05.
Results
We first examined the association of each lipid species with SBP, DBP, and MAP after adjusting for age, age 2 , sex, age×sex interaction, age 2 ×sex interaction, HDL and LDL fractions, body mass index, homeostasis model of assessment-insulin resistance, lipid-lowering medication use, and antihypertensive drug use. Table 1 shows the statistically significant results for at least 2 of the 3 outcomes (full results for all lipid species are shown in Table S1 in the online-only Data Supplement). We found that after accounting for the aforementioned covariates was consistently associated with SBP, DBP, and MAP was DG 16:0/22:5-a 1 SD increase in this lipid species was associated with ≈0.14, 0.15, and 0.16 SD increase in SBP, DBP, and MAP, respectively. Furthermore, this species explained 1.27%, 1.61%, and 1.69% variance of SBP, DBP, and MAP, respectively.
We next considered the association of individual lipid species with the genetic liability of incident hypertension in the subset of initially normotensive subjects (n=736). Using polygenic regression models in the context of discrete trait analysis (implying a liability threshold model), we observed that there were a total of 100 lipid species that were nominally significantly associated with the liability of incident hypertension. However, when we adjusted these associations for multiple comparisons using false discovery rate method, we found that only 3 lipid species retained their statistical significance at a false discovery rate-corrected P value of 0.05. These were 1 phosphatidylethanolamine species (PE 40:6) and 2 diacylglycerol species (DG 16:0/22:5 and DG 16:0/22:6). The polygenic regression coefficients (false discovery rate-corrected P) were −0.3668 (0.0158), −0.3934 (0.0141), and -0.3984 (0.0089), respectively. These regression coefficients translated to relative risks of incident hypertension of 1.92, 2.01, and 2.03, respectively. The Kullback-Leibler R 2 values for these 3 species were 7.4%, 6.0%, and 5.7%, respectively. Full results for all the 319 lipid species are provided in Table S2 . In the regression models presented so far, we had used the HDL and LDL subfractions as covariates. We reasoned that the subfractions would be more informative than the commonly used clinical characteristics, such as total serum cholesterol, triglycerides, and HDL levels. Therefore, we conducted all these analyses by adjusting for these clinically used indexes and found that the interpretations were similar, and there was an ≈80% concordance in the results obtained by the 2 different adjustments in multivariate regressions (Table S3 and Figure S1 ). In addition, our interpretations remained robust even after adjusting for baseline SBP and DBP (Table S4 ). We then examined whether the liability of incident hypertension and the 14 lipid species that showed significant association with blood pressure shared common genetic determinants. For this, we conducted a series of bivariate analyses after correction for all the aforementioned covariates, as well as for multiple comparisons. As shown in Table 2 , we found that 4 lipid species demonstrated statistically significant genetic correlations with hypertension, all of which were diacylglycerols that contained palmitic acid (16:0). All of these 4 lipid species also demonstrated statistically significant environmental correlation with liability of incident hypertension; however, the point estimates of the environmental correlation coefficients were very small compared with the genetic correlation coefficients, indicating that the phenotypic correlation between these diacylglycerols and liability of incident hypertension was mainly caused by the genetic component.
Discussion
Derangement of lipid metabolism is one of the key characteristics of hypertension. [6] [7] [8] [9] [10] Currently, to our knowledge, there exists only 1 case-control study in men that has attempted to uncover the underpinnings of the lipid-blood pressure nexus. 17 Our study is the largest such study, includes substantially higher number of detected lipid species, and is the first study in Mexican Americans. Although our results partly agree with those of Graessler et al, 17 they do offer additional insights into the pathophysiology of hypertension.
In our study, the most significant class of lipids associated with the risk of hypertension was diacylglycerols. In this context, it is interesting that vasopressins are known to bind G-protein-coupled receptors and activate the intracellular phospholipase C. 39 Diacylglycerol is an end product of this reaction, and, along with the second messenger inositol-1,4,5-triphosphate, it regulates the cytosolic calcium ion concentration and protein kinase C activity. Therefore, there is a strong biological plausibility for the role of diacylglycerols in hypertension pathophysiology. The involvement of these lipid classes suggests a distinct and specific upregulation of the diacylglycerol axis in the pathogenesis of hypertension. It should be noted that evidence demonstrating a correlation between plasma diacylglycerol concentrations and intracellular signaling involving diacylglycerols is currently lacking. However, the lipid metabolite hypothesis states that an increase in the plasma-free fatty acid levels is associated with intramyocytic and intrahepatic generation and congregation of several reesterified metabolites that include acyl-coenzyme A and diacylglycerol. 40 Although the reasons for increase in intracellular diacylglycerols in response to lipid infusions are currently not understood, it is conceivable that the plasma levels of some diacylglycerol species may track the myocytic potential to generate intracellular secondary messengers like diacylglycerol and thereby serve as biomarkers of hypertension, especially if this mechanism is operational in the vascular smooth muscle cells. It is noteworthy in this context that the TRPC6 channel expressed widely in vascular smooth muscles is a potent regulator of the Ca 2+ fluxes and is activated by diacylglycerol. 41, 42 The other class of interest observed in our study was that of monohexosylceramides. Jiang et al 43 recently demonstrated that ceramides can mediate vascular dysfunction by inhibiting the endothelial nitric oxide synthase-serine/threonine protein kinases-heat shock protein90 (eNOS/Akt/Hsp90) signaling complex. Thus, ceramides and their analogs can be expected to contribute to hypertension pathophysiology by way of endothelial dysfunction as also observed by Spijkers et al. 27 The DG 16:0/22:5 lipid species was (1) consistently associated with increased SBP, DBP, and MAP; (2) strongly associated with liability of incident hypertension; and (3) strongly genetically correlated with the liability of incident hypertension. With the exception of a marginally significant association with DBP, the DG 16:0/22:6 lipid species also closely followed pattern of associations demonstrated by the DG 16:0/22:5 lipid species. These observations combined with the finding that all 16:0 fatty acid containing diacylglycerols were strongly genetically correlated with incident hypertension point toward the potential association of palmitic acid with hypertension. Previous studies [44] [45] [46] [47] have demonstrated this relationship, and our results afford additional credence to it. Of more interest, however, is our finding that not all diacylglycerol species can be equally implicated in the pathophysiology of hypertension. For example, the genetic correlations of the 16:1 or 18:0 containing diacylglycerols with the liability of incident hypertension were considerably smaller compared with the 16:0 containing diacylglycerols. These findings are important because they underscore the precision and resolution of lipidomic studies. Our results indicate that the DG 16:0/22:5 and DG 16:0/22:6 lipid species may be important drug targets or modifiable factors that can be advantageously used in early detection, risk stratification, or prevention of hypertension.
There are 5 important limitations of this study. First, there exists a tight association between hypertension and other components of metabolic disease, and this makes it difficult to differentiate between independent and intermediate associations. Boden 40 has reviewed the mechanisms that lead to insulin resistance consequent to inflammation induced by fatty acids. Plasma-free fatty acids lead to accumulation of diacylglycerols and triacylglycerols in the liver and muscles and activate some serine/threonine kinases. These mechanisms are also common to the pathogenesis of hypertension and cardiovascular conditions. Our analytic approach was similar to that used by Graessler et al, 17 in which all statistical models were adjusted for body mass index and homeostasis model of assessmentinsulin resistance. Therefore, the associations reported here are less likely to have been influenced by other traits implicit in metabolic syndrome. Second, our definition of hypertension was based on cross-sectionally and longitudinally detected rise in blood pressure. The actual predictability of the lipid species in the context of future hypertension is unknown. Nevertheless, the consistency of associations of the lipid species with SBP, DBP, MAP, and hypertension indicates that our definition of hypertension is unlikely to have confounded the results or interpretations. Third, the plasma lipidomic profile itself has been shown to vary across men and women 17, 48 as do several key pathways involved in hypertension. However, our primary aim was to investigate the association between lipid species and hypertension, regardless of sex; therefore, in our analytic protocol, we adjusted all the models for age, sex, and their interactions. Fourth, observational studies of this nature can be biased by the inadequacy of information related to treatment effects.
With special reference to incident hypertension, it is conceivable that the use of lipid-lowering drugs may influence both the abundance of the lipid species in plasma and the risk of hypertension. However, only 1.8% of the study subjects were receiving lipid-lowering agents, and we, therefore, believe that our results are unlikely to be significantly affected by drug use. Finally, we did not have data on kidney function tests during the first visit of the study participants. However, when we correlated the SBP, DBP, and MAP measured during the third visit with the estimated glomerular filtration rate (also measured in the third visit samples), we found no association among the blood pressure measurements and kidney function (data not shown). Furthermore, none of the 319 lipid species was significantly associated with estimated glomerular filtration rate. These findings indirectly imply that the association of diacylglycerol species with blood pressure observed in this study is unlikely to be because of an association with kidney function.
Perspectives
Our study demonstrates the added and independent association of plasma lipidomic profiles with blood pressure and incident hypertension in Mexican American families. The technology of lipidomic profiling is constantly evolving, and its use in detection of complex diseases, such as hypertension and metabolic syndrome, can also be envisioned in the near future. In that context and to that end, our study shows novel and important lipidomic signatures of blood pressure and hypertension. More studies that replicate these findings are warranted. Future studies also need to intensively investigate the possibilities related to the putative role of diacylglycerols (specifically the DG 16:0/22:5 and DG 16:0/22:6 species) in blood pressure regulation and hypertension. Because hypertension is itself a risk factor for numerous cardiovascular disorders, it is conceivable that these 2 lipid species found to be significantly associated with a risk of incident hypertension may be useful in the prevention of cardiovascular diseases, especially because increased plasma concentrations of these 2 lipid species may be harbingers of impending derangements ultimately culminating in cardiovascular morbidity. Our results, therefore, open several potential leads into the characterization of the role of lipidomic studies in hypertension. 
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